News Search Results
Jul 07, 2025, 14:00 ET Myosin Therapeutics Publishes Two Foundational Studies in the Journal Cell Highlighting a Novel Approach to Treating Cancer and Brain Disorders
Myosin Therapeutics, a clinical-stage biotechnology company advancing first-in-class therapies targeting molecular motor proteins, announced the publication of two major papers in the journal Cell
More news about: Myosin Therapeutics Inc.
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 07, 2025, 11:59 ET 26th Edition Global Family Office Investment Summit Held in Cannes Under the Patronage of Cannes Mayor H.E. David Lisnard
Artificial Intelligence & Web3 InnovationSustainable Infrastructure & Renewable EnergyHealthcare, Biotechnology & LongevityPhilanthropy, Family Legacy & GovernanceReal Estate, Private Equity & Global MarketsCross-border
More news about: Ritossa Family Office
Jul 07, 2025, 11:50 ET Cervical Cancer Treatment Market Size is Expected to Reach USD 14.91 Billion by 2030, with CAGR of 5.7%, Rising Prevalence of Cervical Cancer Fuels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 07, 2025, 11:30 ET mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight Partners
end user, the mRNA sequencing market is segmented into healthcare facilities, pharmaceutical and biotechnology companies, clinical research organizations, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2024.The mRNA sequencing market
More news about: The Insight Partners
Jul 07, 2025, 11:15 ET Procedure Trays Market Size Projected to Exceed USD 49.32 Billion by 2031 at a 10.2% CAGR, Driven by Increasing Surgical Procedures and Emphasis on Infection Control | The Insight Partners'
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 07, 2025, 10:31 ET World-Class, Turnkey Cro Facility Available Through Bankruptcy Sale with Full Suite of Lab Equipment & Intellectual Property
features sophisticated infrastructure and enhanced security for sensitive operations. Engineered to support the development of pharmaceuticals, biotechnology products and medical devices, the facility's integrated laboratories are designed to deliver toxicology, safety pharmacology and bioanalytic characterization
More news about: Hilco Global
Jul 07, 2025, 10:15 ET Biochip Market to Reach USD 17.99 Billion by 2030 -- Driven by Diagnostics, Personalized Medicine, and Drug Discovery | Valuates Reports
July 7, 2025 /PRNewswire/ -- Biochip Market is Segmented by Type (Microarrays, Microfluidics), by Application (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes).
More news about: Valuates Reports
Jul 07, 2025, 10:01 ET Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
patients benefit from safer, more effective therapies. Understanding the Platform Calidi Biotherapeutics is clinical stage biotechnology company that is developing genetic medicines and proprietary genetically engineered oncolytic viruses. Calidi's RedTail systemic antitumor virotherapy
More news about: NetworkNewsWire
Jul 07, 2025, 08:30 ET Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
patients benefit from safer, more effective therapies. Understanding the Platform Calidi Biotherapeutics is clinical stage biotechnology company that is developing genetic medicines and proprietary genetically engineered oncolytic viruses. Calidi's RedTail systemic antitumor virotherapy
More news about: NetworkNewsWire
Jul 07, 2025, 08:05 ET Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
employees vesting over four years with a one-year cliff. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Jul 07, 2025, 01:00 ET Nuevocor Strengthens Board with Appointment of Thierry Abribat
-- Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the appointment of Dr. Thierry
More news about: Nuevocor
Jul 04, 2025, 11:30 ET Digital Twin Market Size to hit USD 140.93 billion by 2031, Experiences Growth Due to Increasing Adoption of IoT Devices, Large-Scale Digital Transformation | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 04, 2025, 10:50 ET Printed Electronics Market Size to Reach USD 60.18 Billion by 2031, Experiences Growth Owing to the Technological Advancements and Increasing Demand across Sectors | Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 04, 2025, 10:30 ET Wearable EEG Devices Market Size to Grow by USD 695.51 million by 2031, Experiences Growth Owing to Growing Prevalence of Neurological Disorders | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 04, 2025, 09:30 ET HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025
BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory
More news about: HotSpot Therapeutics
Jul 03, 2025, 20:30 ET Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
Brii Biosciences Limited ("Brii Bio," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical needs, today
More news about: Brii Biosciences Limited
Jul 03, 2025, 16:04 ET Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announces the acceptance for publication of a research article entitled "Liposomal-Cannabidiol Injection: Preliminary Insights into
More news about: Innocan Pharma Corporation
Jul 03, 2025, 16:01 ET Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announces the acceptance for publication of a research article entitled "Liposomal-Cannabidiol Injection: Preliminary Insights into
More news about: Innocan Pharma Corporation
Jul 03, 2025, 14:15 ET RCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
[email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Jul 03, 2025, 13:49 ET Dr. Aubrey de Grey Brings Cutting-Edge Science to RAADfest 2025: LEV Foundation Partners with Coalition for Radical Life Extension
nonprofit organization founded by Dr. Aubrey de Grey to accelerate the development and deployment of rejuvenation biotechnology. The Foundation focuses on damage repair approaches to aging and conducting combination therapy studies that demonstrate significant life extension
More news about: LEV Foundation
Jul 03, 2025, 11:30 ET Photovoltaic Market Size to Reach USD 1,145.70 billion by 2031, Experiences Increasing Demand for Solar Panels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 03, 2025, 11:15 ET Secure Logistics Market Size Grows to USD 84.39 Billion by 2031 | CAGR of 5.2% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners